McGuire FP et al
Currently, GPx3 is considered a new tumor-suppressor gene [23], and its hypermethylation, which is associated with the further down-regulation of GPx3, was observed in patients with Barretts esophagus [54], endometrial adenocarcinoma [55] and prostate cancer [56]
Ali, MD 1 1University of Arkansas for Medical Sciences, Little Rock, AR
A meta-analysis of seven SURPASS clinical trials in participants with T2DM showed the hazard ratios comparing tirzepatide versus controls of 0.80 (95% CI, 0.57 1.11) for 4-MACE, 0.90 (95% CI, 0.50 1.61) for cardiovascular death, and 0.80 (95% CI, 0.51 1.25) for all-cause mortality (264)
I take 1g 1st thing in the morning (also with jarrow True Focus - also a great product) and sometimes 500mg with the afternoon meal (tried 1g but can't fall asleep too easy)